Literature DB >> 23893385

Clinic significance of microRNA-99a expression in human lung adenocarcinoma.

Wei Gu1, Surong Fang, Lihua Gao, Yan Tan, Zhenhua Yang.   

Abstract

BACKGROUND: The purpose of this study was to investigate the clinical significance of microRNA-99a expression in lung adenocarcinoma.
METHODS: qRT-PCR assay was performed to detect miR-99a expression in lung adenocarcinoma cells or tissues. The correlations of miR-99a expression with clinicopathological factors and prognosis of lung adenocarcinoma patients were analyzed. The effects of miR-99a expression on growth and apoptosis of lung adenocarcinoma cell line and its potential target gene were determined by MTT, flow cytometry, luciferase reporter, and Western blot assays.
RESULTS: The relative miR-99a expression in lung adenocarcinoma cells was significantly lower than that in normal lung bronchial epithelium cell line. Also, miR-99a expression in lung adenocarcinoma tissues was significantly lower than that in corresponding nontumor tissues. Low miR-99a expression was found to be closely correlated with advanced clinical stage and lymph node metastasis. Kaplan-Meier survival and Cox regression analyses showed that the status of miR-99a expression was an independent prognosis factor for lung adenocarcinoma patients. Functional analyses showed that upregulation of miR-99a could inhibit growth and induce apoptosis in lung adenocarcinoma cells by targeting mTOR.
CONCLUSION: Low MiR-99a expression was a poor prognostic factor for patients with lung adenocarcinoma, and miR-99a functions as a tumor suppressor by targeting mTOR.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  lung adenocarcinoma; mTOR; microRNA-99a; prognosis; qRT-PCR

Mesh:

Substances:

Year:  2013        PMID: 23893385     DOI: 10.1002/jso.23381

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  IMP3 Predicts Invasion and Prognosis in Human Lung Adenocarcinoma.

Authors:  Jinhai Yan; Qingzhu Wei; Wenjing Jian; Bo Qiu; Jing Wen; Jianghuan Liu; Bo Fu; Xinhua Zhou; Tong Zhao
Journal:  Lung       Date:  2015-11-25       Impact factor: 2.584

2.  The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression.

Authors:  Jun Huang; U-Ging Lo; Shiqi Wu; Bin Wang; Rey-Chen Pong; Chih-Ho Lai; Ho Lin; Dalin He; Jer-Tsong Hsieh; Kaijie Wu
Journal:  Cell Death Dis       Date:  2019-06-04       Impact factor: 8.469

3.  MiR-195-3p is a Novel Prognostic Biomarker Associated with Immune Infiltrates of Lung Adenocarcinoma.

Authors:  Yi Lao; Taidong Li; Xin Xie; Kangbiao Chen; Ming Li; Lu Huang
Journal:  Int J Gen Med       Date:  2022-01-06

4.  Expression, Clinical Significance, Immune Infiltration, and Regulation Network of miR-3940-5p in Lung Adenocarcinoma Based on Bioinformatic Analysis and Experimental Validation.

Authors:  Zhichao Lin; Wenhai Huang; Zehua Xie; Yongsheng Yi; Zumei Li
Journal:  Int J Gen Med       Date:  2022-08-06

5.  MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinoma.

Authors:  J Zhang; H Jin; H Liu; S Lv; B Wang; R Wang; H Liu; M Ding; Y Yang; L Li; J Zhang; S Fu; D Xie; M Wu; W Zhou; Q Qian
Journal:  Oncogenesis       Date:  2014-04-14       Impact factor: 7.485

6.  Aberrant expression of microRNA-99a and its target gene mTOR associated with malignant progression and poor prognosis in patients with osteosarcoma.

Authors:  Jiali Zhao; Fengli Chen; Quan Zhou; Wei Pan; Xinhong Wang; Jin Xu; Li Ni; Huilin Yang
Journal:  Onco Targets Ther       Date:  2016-03-17       Impact factor: 4.147

7.  Predicting MicroRNA Biomarkers for Cancer Using Phylogenetic Tree and Microarray Analysis.

Authors:  Hsiuying Wang
Journal:  Int J Mol Sci       Date:  2016-05-19       Impact factor: 5.923

8.  Biological role and clinical value of miR-99a-5p in head and neck squamous cell carcinoma (HNSCC): A bioinformatics-based study.

Authors:  Yu-Ting Chen; Jian-Ni Yao; Yu-Tao Qin; Kai Hu; Fang Wu; Ye-Ying Fang
Journal:  FEBS Open Bio       Date:  2018-06-26       Impact factor: 2.693

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.